Marginated neutrophils in the lungs effectively compete for nanoparticles targeted to the endothelium, serving as a part of the reticuloendothelial system

Marco E. Zamora(Translational Therapeutics (United States)), Edward Cantu(Hospital of the University of Pennsylvania), Tea Shuvaeva(Translational Therapeutics (United States)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Joseph D. Planer(Pulmonary and Allergy Associates), Kara L. Spiller(Drexel University), Mortimer Poncz(University of Pennsylvania), Jarod A. Zepp(Children's Hospital of Philadelphia), Carolann Espy(Translational Therapeutics (United States)), Aditi Murthy(Pulmonary and Allergy Associates), Serena Omo‐Lamai(University of Pennsylvania), Maria C. Basil(Boston University), Sachchidanand Tiwari(Jawaharlal Nehru University), Evguenia Arguiri(Translational Therapeutics (United States)), Jacob W. Myerson(Translational Therapeutics (United States)), Jia Nong(University of Pennsylvania), Oscar A. Marcos‐Contreras(University of Pennsylvania), Lubica Rauova(Children's Hospital of Philadelphia), Kartik Bhamidipati(Translational Therapeutics (United States)), Manthan N. Patel(Translational Therapeutics (United States)), Jichuan Wu(University of Pennsylvania), Fatima Chaudhry(Children's Hospital of Philadelphia), Elizabeth D. Hood(Translational Therapeutics (United States)), Zhicheng Wang(Central South University), Jing Liu(Anhui Jianzhu University), Hyun‐Jun Kim(Children's Hospital of Philadelphia), Laura T. Ferguson(Pulmonary and Allergy Associates), Eno‐Obong Essien(Translational Therapeutics (United States))
bioRxiv (Cold Spring Harbor Laboratory)
June 10, 2024
Cited by 1


Related Papers